Glucocorticoids (GCs) are the most effective treatment currently available for many allergic and inflammatory diseases. However, the severe side effects have limited their therapeutic usefulness. The development of topical or inhaled agents has been attempted to improve the therapeutic use of GCs. However, recent elucidation of the molecular mechanisms of GC action has led to a new strategy. The glucocorticoid receptor (GR) regulates gene transcription by two different mechanisms, namely, transactivation and transrepression.
study was performed in accordance with the guidelines for animal experiments of Taiho Pharmaceutical Co., Ltd.
Determination of Luciferase Activity in Skin Mouse skin was excised, soaked in 500 ml of cell culture lysis reagent (Promega, Madison, WI, U.S.A.), and homogenized using a Mixer Mill MM300 (Retsch, Germany). After centrifugation at 10000ϫg for 5 min, 20 ml of supernatant was added to 100 ml of luciferase assay reagent (Promega) and counted with a luminescencer AB-2000 (Atto, Tokyo, Japan).
Cell Culture and Reporter Gene Assay HeLa cells were purchased from Dainippon Pharm. (Osaka, Japan) and were maintained at 37°C and 5% CO 2 in Eagle's minimum essential medium (MEM) supplemented with 10% fetal calf serum, 100 U/ml penicillin and 0.1 mg/ml streptomycin. The cells were seeded in 24-well plates such that they were subconfluent at the time of the experiment. For the reporter gene assay, the cells in each well were transiently transfected with the indicated amounts of either pBK-CMV or pBK-hGR (0.1 mg) and pMAMneoLUC (0.3 mg) using Superfect Transfection Reagent (Qiagen, Venlo Park, The Netherlands) in MEM. After 6 h, the transfection mixture was replaced with MEM. The cells were starved overnight, treated with prednisolone for 16 h, and lysed with 100 ml of cell culture lysis reagent. The luciferase activity was measured as described above.
Effects of Prednisolone on Thymus Weight and Serum Corticosterone Level in Mice Prednisolone or vehicle (saline containing 0.5% Tween80) was administered subcutaneously to the mice once daily for 7 d. Twenty-four hours after the last dose, the mice were killed by intraperitoneal injection of pentobarbital. Blood was collected from the inferior vein to collect serum by centrifugation. The thymus was dissected and weighed. Concentrations of corticosterone in the serum were measured using a corticosterone [
125 I] assay system (Amersham, England).
Data Analysis The statistical differences between groups were analyzed by Dunnett's multiple range test. A p value of less than 0.05 was considered to be statistically significant.
RESULTS

Measurement of GR-Mediated Transactivation in Vivo
As a reporter plasmid to evaluate the transactivation function of GR, pMAMneoLUC was chosen. This plasmid encodes the luciferase gene controlled by the mouse mammary tumor virus (MMTV) long terminal repeat that contains several GREs. To measure the transactivation activity in vivo, this reporter plasmid was inoculated together with the GR expression plasmid, pBK-hGR, into mouse abdominal skin, and the luciferase expression was measured 1, 3, 6 and 10 h after subcutaneous administration of prednisolone to the interscapular area. Prednisolone was administered in the morning around 9:00 a.m. when the endogenous level of corticosterone is minimum. The enhancement of luciferase activity by prednisolone (10 mg/kg, s.c.) could be detected from 1 h after the administration and the maximal induction was observed after 6 h ( Fig. 1 ). At this time point, the induction was dose-dependent of prednisolone and dexamethasone (Fig. 2) . No induction was observed with vehicle alone, indicating that the endogenous level of GC was negligible in this protocol. In addition, this induction is strictly dependent on GR because no induction of luciferase was observed when the GR expression plasmid was not co-transfected with the reporter plasmid (data not shown).
Enforced Expression of GR is Necessary to Increase the Sensitivity of the Reporter Gene Assay As co-transfection of the GR expression plasmid was required to detect the transactivation activity in vivo, the effect of overexpression of GR was investigated in an in vitro reporter gene assay using HeLa cells. This cell line reportedly expresses endogenous GR as evidenced by the inhibition of TNF-induced IL-6 production by GCs. 10) In the cells transiently transfected with the pMAMneoLUC reporter plasmid alone, prednisolone at 1 mM induced an approximately 10-fold increase luciferase activity compared with the basal activity (Fig. 3) . When the GR expression plasmid was co-transfected, the induction was augmented up to approximately 150-fold in a manner depending on the amount of the plasmid, suggesting that co-transfection of the GR increases the sensitivity of the assay.
Comparison with the Sensitivity of Physiological Side Effects To compare the sensitivity of this method with those of systemic side effects, the effects of prednisolone on both the thymus weight and serum corticosterone level were examined after subcutaneous administration for 7 d. Prednisolone at 3 mg/kg, which is the minimum dose to induce luciferase activity in the reporter assay, evoked strong de- Prednisolone (10 mg/kg) was subcutaneously administrated to reporter gene and GR expression plasmid-co-introduced mice at 9:00 a.m. At the indicated times, mice skin was excised, and assayed for luciferase activity. The data are expressed as meanϮS.E. of eight animals. * pϽ0.05 and ** pϽ0.01 for the significant differences from basal value at to (Dunnett's multiple range test).
Fig. 2. Effect of Glucocorticoids on MMTV Transactivation Activity in Vivo
creases in the thymus weight, although the corticosterone levels were scarcely affected (Fig. 4) . At the higher dose, the corticosterone levels were also decreased remarkably. These results indicate that the sensitivity of our protocol is comparable to that of physiological changes induced by GCs.
DISCUSSION
GCs are the most potent anti-inflammatory and immunosuppressive drugs, while they are accompanied by a wide range of adverse effects. The most probable strategy to separate beneficial from adverse effects is presumed to involve the dissociation of transactivation and transrepression of GC action. Although transactivation activity can be easily determined by an in vitro reporter gene assay, in vivo efficacy is influenced by various factors, including absorption and metabolism, and does not necessarily correlate with the data obtained in vitro. This is indeed the case for RU24858, which demonstrates a dissociated profile in vitro but elicits side effects in vivo with similar potency to the standard glucocorticoid, budesonide. 5, 11) In this regard, the method in our study would be beneficial to evaluate GR-mediated transactivation in vivo with the same parameters as in vitro. In some studies, 12, 13) the induction of tyrosine aminotransferase in the liver was assessed as an index of transactivation, but our protocol is simpler and more convenient.
The idea of dissociated ligand is supported in part by the analysis of mutant mice carrying the mutation that abrogates the transactivation function of GR. 13, 14) These mice are resistant to thymus involution by GCs, whereas the repression of AP-1-induced gene expression is intact. However, it is not clear what kind of and to what extent other types of adverse effects, such as osteoporosis, lipid redistribution, and glucose intolerance, are dependent on GR-mediated transactivation. One approach to solve this issue is to analyze the relationship between the physiological changes and transactivation activity of various ligands. For such studies, the method described in this paper would be suitable in that both factors can be measured in vivo. In addition, this protocol would be useful for the development of non-steroidal ligands for GR. 15) If such a ligand exhibits some side effects in vivo, our protocol may indicate whether it is due to GR-mediated transactivation or due to an other mechanism derived from its novel structure.
The assay method in this paper is specifically dependent on GR, because the induction of reporter gene was not observed in the absence of the GR expression plasmid. It is likely that the cells in the skin, probably fibroblasts and keratinocytes, express endogenous GR, but the enforced expression of the GR was required to induce detectable levels of the reporter gene expression in the present protocol. Our in vitro analysis showed that, although the endogenous level of the GR in HeLa cells is sufficient for the reporter gene expression, overexpression of the GR strongly enhances the levels of such expression. Similar findings were reported by Szapary et al. 16) using another reporter plasmid that is controlled by a tandem repeat of GRE instead of the MMTV promoter. Therefore, the magnitude of this assay must be dependent on the number of GR, and high magnitude is necessary to detect an in vivo response. Nevertheless, the dose response of prednisolone in the present protocol is comparable to that for the decrease in thymus weight and serum corticosterone level. Moreover dexamethasone showed approximately 10 times higher transactivation activity than prednisolone (Fig. 2) , and this difference appears to be consistent with clinical report that dexamethasone showed 5-7 times higher potency to affect hypothalamic-pituitary-adrenocortical axis than prednisolone. 17) These results suggest that the sensitivity of our protocol is suited to predict physiological responses induced by GCs.
The gene gun has been used mostly for DNA immunization, vaccination, and the expression of functional proteins. This paper demonstrates the in vivo performance of a reporter gene assay and suggests another area for the application of gene gun DNA delivery. Prednisolone was subcutaneously administrated to ICR mice once daily for 7 d. The data are expressed as meanϮS.E. of eight animals. ** pϽ0.001 and *** pϽ0.0001 for the significant differences between vehicle group and prednisolone treatment group (Dunnett's multiple range test).
